4//SEC Filing
MOYES JAY M 4
Accession 0001437749-23-017610
CIK 0001401667other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:10 PM ET
Size
13.3 KB
Accession
0001437749-23-017610
Insider Transaction Report
Form 4
MOYES JAY M
Director
Transactions
- Sale
Common Stock
2023-06-13$3.45/sh−22,000$75,970→ 16,322 total - Award
Common Stock
2023-06-13+27,000→ 43,322 total
Footnotes (3)
- [F1]Adoption date of referenced 10b5-1(c) sell to cover program is: 12-16-2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F3]Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001191062
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 9:10 PM ET
- Size
- 13.3 KB